Cochlear Limited (ASX: COH) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Cochlear Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Cochlear Limited (ASX: COH)
Latest News
⏸️ ASX Shares
These ASX 200 healthcare shares could be long term market beaters
⏸️ TMF AMP
5 things to watch on the ASX 200 on Tuesday
⏸️ ASX Shares
Grow your wealth with these quality ASX healthcare shares
⏸️ ASX Shares
3 blockbuster ASX blue chip shares to buy
Healthcare Shares
Top broker warns CSL share price set to fall over the next month
Share Market News
How Cochlear is helping implant users during the COVID-19 pandemic
Personal Finance
My final tip to help you prepare for a recession in 2020
Coronavirus News
Coronavirus capital raisings on the rise
Share Market News
5 ASX shares to buy at deep discounts today
Coronavirus News
Is it time to buy Coca Cola Amatil shares?
Share Market News
The ASX 200 was very volatile again this week
Resources Shares
Why these ASX miners could outperform over the next two months
Frequently Asked Questions
-
Yes, Cochlear Ltd has historically paid two fully franked dividends a year.
-
Cochlear Ltd generally pays its dividends in April and October.
-
Cochlear Ltd listed on the ASX on 4 December 1995.
COH ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Cochlear Limited
Cochlear Ltd (ASX: COH) is the world's leading cochlear implant device manufacturer with around half of global market share.
The company was founded in Australia in 1983 to commercialise implants pioneered by Melbourne researcher Dr Graeme Clark, but later became a separate entity.
Developed markets contribute the bulk of Cochlear's group revenue with cochlear implants the standard of care for children with severe to profound hearing loss. The company is also catering for a growing cohort of seniors when standard hearing aid technology loses its effectiveness.
Cochlear's main products include cochlear implants, bone-anchored hearing devices, and associated sound processors. The vast majority of Cochlear's revenue is derived from overseas, with the US and Europe by far the company's two largest markets.
